Cargando…
The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1
BACKGROUND: Tuberous Sclerosis Complex (TSC) and Neurofibromatosis type 1 (NF1) are neurocutaneous disorders commonly characterized by neuropsychiatric comorbidities. The TAND (Tuberous Sclerosis Associated Neuropsychiatric Disorders) Checklist is currently used to quickly screen for behavioural, ps...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487732/ https://www.ncbi.nlm.nih.gov/pubmed/32894194 http://dx.doi.org/10.1186/s13023-020-01488-4 |
_version_ | 1783581548214222848 |
---|---|
author | Cervi, Francesca Saletti, Veronica Turner, Katherine Peron, Angela Bulgheroni, Sara Taddei, Matilde La Briola, Francesca Canevini, Maria Paola Vignoli, Aglaia |
author_facet | Cervi, Francesca Saletti, Veronica Turner, Katherine Peron, Angela Bulgheroni, Sara Taddei, Matilde La Briola, Francesca Canevini, Maria Paola Vignoli, Aglaia |
author_sort | Cervi, Francesca |
collection | PubMed |
description | BACKGROUND: Tuberous Sclerosis Complex (TSC) and Neurofibromatosis type 1 (NF1) are neurocutaneous disorders commonly characterized by neuropsychiatric comorbidities. The TAND (Tuberous Sclerosis Associated Neuropsychiatric Disorders) Checklist is currently used to quickly screen for behavioural, psychiatric, intellectual, academic, neuropsychological and psychosocial manifestations in patients with TSC. We administered the authorized Italian version of the TAND Checklist to the parents of 42 TSC patients and 42 age- and sex-matched NF1 patients, for a total of 84 individuals, aged 4–20 years. Aims of this study: - to test the overall usability of the TAND Checklist in NF1, −to compare the results between children and adolescents with TSC and NF1, and -to examine the association between neuropsychiatric manifestations and severity of the phenotype in terms of epilepsy severity in the TSC cohort and disease severity according to the modified version of the Riccardi severity scale in the NF1 cohort. RESULTS: TSC cohort: 35.6% had Intellectual Disability (ID), 11.9% Specific Learning Disorders (SLD), 50.0% Attention Deficit Hyperactivity Disorder (ADHD) and 16.6% anxious/mood disorder. 33.3% had a formal diagnosis of Autism Spectrum Disorder (ASD). Paying attention and concentrating (61.9%), impulsivity (54.8%), temper tantrums (54.8%), anxiety (45.2%), overactivity/hyperactivity (40.5%), aggressive outburst (40.5%), absent or delayed onset of language (40.5%), repetitive behaviors (35.7%), academic difficulties (> 40%), deficits in attention (61.9%) and executive skills (50.0%) were the most commonly reported problems. NF1 cohort: 9.5% had ID, 21.4% SLD, 46.6% ADHD, and 33.3% anxious/mood disorder. No one had a diagnosis of ASD. Commonly reported issues were paying attention and concentrating (59.5%), impulsivity (52.4%), anxiety (50.0%), overactivity/hyperactivity (38.1%), temper tantrums (38.1%), academic difficulties (> 40%), deficits in attention (59.5%), and executive skills (38.1%). Neuropsychiatric features in TSC vs NF1: Aggressive outburst and ASD features were reported significantly more frequently in TSC than in NF1. Neuropsychiatric manifestations and phenotype severity: Depressed mood, absent or delayed onset of language, repetitive language, difficulties in relationship with peers, repetitive behaviors, spelling, mathematics, dual-tasking, visuo-spatial tasks, executive skills, and getting disoriented were significantly different among TSC patients with different epilepsy severity. No statistically significant differences in the NF1 subgroups were noted for any of the items in the checklist. CONCLUSION: The TAND Checklist used for TSC is acceptable and feasible to complete in a clinical setting, and is able to detect the complexity of neuropsychiatric involvement in NF1 as well. NF1 is mainly characterized by an ADHD profile, anxiety problems and SLD, while ASD features are strongly associated with TSC. In conclusion, the TAND Checklist is a useful and feasible screening tool, in both TSC and NF1. |
format | Online Article Text |
id | pubmed-7487732 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-74877322020-09-16 The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1 Cervi, Francesca Saletti, Veronica Turner, Katherine Peron, Angela Bulgheroni, Sara Taddei, Matilde La Briola, Francesca Canevini, Maria Paola Vignoli, Aglaia Orphanet J Rare Dis Research BACKGROUND: Tuberous Sclerosis Complex (TSC) and Neurofibromatosis type 1 (NF1) are neurocutaneous disorders commonly characterized by neuropsychiatric comorbidities. The TAND (Tuberous Sclerosis Associated Neuropsychiatric Disorders) Checklist is currently used to quickly screen for behavioural, psychiatric, intellectual, academic, neuropsychological and psychosocial manifestations in patients with TSC. We administered the authorized Italian version of the TAND Checklist to the parents of 42 TSC patients and 42 age- and sex-matched NF1 patients, for a total of 84 individuals, aged 4–20 years. Aims of this study: - to test the overall usability of the TAND Checklist in NF1, −to compare the results between children and adolescents with TSC and NF1, and -to examine the association between neuropsychiatric manifestations and severity of the phenotype in terms of epilepsy severity in the TSC cohort and disease severity according to the modified version of the Riccardi severity scale in the NF1 cohort. RESULTS: TSC cohort: 35.6% had Intellectual Disability (ID), 11.9% Specific Learning Disorders (SLD), 50.0% Attention Deficit Hyperactivity Disorder (ADHD) and 16.6% anxious/mood disorder. 33.3% had a formal diagnosis of Autism Spectrum Disorder (ASD). Paying attention and concentrating (61.9%), impulsivity (54.8%), temper tantrums (54.8%), anxiety (45.2%), overactivity/hyperactivity (40.5%), aggressive outburst (40.5%), absent or delayed onset of language (40.5%), repetitive behaviors (35.7%), academic difficulties (> 40%), deficits in attention (61.9%) and executive skills (50.0%) were the most commonly reported problems. NF1 cohort: 9.5% had ID, 21.4% SLD, 46.6% ADHD, and 33.3% anxious/mood disorder. No one had a diagnosis of ASD. Commonly reported issues were paying attention and concentrating (59.5%), impulsivity (52.4%), anxiety (50.0%), overactivity/hyperactivity (38.1%), temper tantrums (38.1%), academic difficulties (> 40%), deficits in attention (59.5%), and executive skills (38.1%). Neuropsychiatric features in TSC vs NF1: Aggressive outburst and ASD features were reported significantly more frequently in TSC than in NF1. Neuropsychiatric manifestations and phenotype severity: Depressed mood, absent or delayed onset of language, repetitive language, difficulties in relationship with peers, repetitive behaviors, spelling, mathematics, dual-tasking, visuo-spatial tasks, executive skills, and getting disoriented were significantly different among TSC patients with different epilepsy severity. No statistically significant differences in the NF1 subgroups were noted for any of the items in the checklist. CONCLUSION: The TAND Checklist used for TSC is acceptable and feasible to complete in a clinical setting, and is able to detect the complexity of neuropsychiatric involvement in NF1 as well. NF1 is mainly characterized by an ADHD profile, anxiety problems and SLD, while ASD features are strongly associated with TSC. In conclusion, the TAND Checklist is a useful and feasible screening tool, in both TSC and NF1. BioMed Central 2020-09-07 /pmc/articles/PMC7487732/ /pubmed/32894194 http://dx.doi.org/10.1186/s13023-020-01488-4 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Cervi, Francesca Saletti, Veronica Turner, Katherine Peron, Angela Bulgheroni, Sara Taddei, Matilde La Briola, Francesca Canevini, Maria Paola Vignoli, Aglaia The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1 |
title | The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1 |
title_full | The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1 |
title_fullStr | The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1 |
title_full_unstemmed | The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1 |
title_short | The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1 |
title_sort | tand checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487732/ https://www.ncbi.nlm.nih.gov/pubmed/32894194 http://dx.doi.org/10.1186/s13023-020-01488-4 |
work_keys_str_mv | AT cervifrancesca thetandchecklistausefulscreeningtoolinchildrenwithtuberoussclerosisandneurofibromatosistype1 AT salettiveronica thetandchecklistausefulscreeningtoolinchildrenwithtuberoussclerosisandneurofibromatosistype1 AT turnerkatherine thetandchecklistausefulscreeningtoolinchildrenwithtuberoussclerosisandneurofibromatosistype1 AT peronangela thetandchecklistausefulscreeningtoolinchildrenwithtuberoussclerosisandneurofibromatosistype1 AT bulgheronisara thetandchecklistausefulscreeningtoolinchildrenwithtuberoussclerosisandneurofibromatosistype1 AT taddeimatilde thetandchecklistausefulscreeningtoolinchildrenwithtuberoussclerosisandneurofibromatosistype1 AT labriolafrancesca thetandchecklistausefulscreeningtoolinchildrenwithtuberoussclerosisandneurofibromatosistype1 AT canevinimariapaola thetandchecklistausefulscreeningtoolinchildrenwithtuberoussclerosisandneurofibromatosistype1 AT vignoliaglaia thetandchecklistausefulscreeningtoolinchildrenwithtuberoussclerosisandneurofibromatosistype1 AT cervifrancesca tandchecklistausefulscreeningtoolinchildrenwithtuberoussclerosisandneurofibromatosistype1 AT salettiveronica tandchecklistausefulscreeningtoolinchildrenwithtuberoussclerosisandneurofibromatosistype1 AT turnerkatherine tandchecklistausefulscreeningtoolinchildrenwithtuberoussclerosisandneurofibromatosistype1 AT peronangela tandchecklistausefulscreeningtoolinchildrenwithtuberoussclerosisandneurofibromatosistype1 AT bulgheronisara tandchecklistausefulscreeningtoolinchildrenwithtuberoussclerosisandneurofibromatosistype1 AT taddeimatilde tandchecklistausefulscreeningtoolinchildrenwithtuberoussclerosisandneurofibromatosistype1 AT labriolafrancesca tandchecklistausefulscreeningtoolinchildrenwithtuberoussclerosisandneurofibromatosistype1 AT canevinimariapaola tandchecklistausefulscreeningtoolinchildrenwithtuberoussclerosisandneurofibromatosistype1 AT vignoliaglaia tandchecklistausefulscreeningtoolinchildrenwithtuberoussclerosisandneurofibromatosistype1 |